BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22752077)

  • 1. Low doses of anti-CD3, ciclosporin A and the vitamin D analogue, TX527, synergise to delay recurrence of autoimmune diabetes in an islet-transplanted NOD mouse model of diabetes.
    Baeke F; Van Belle TL; Takiishi T; Ding L; Korf H; Laureys J; Gysemans C; Mathieu C
    Diabetologia; 2012 Oct; 55(10):2723-2732. PubMed ID: 22752077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.
    Gysemans C; Van Etten E; Overbergh L; Verstuyf A; Waer M; Bouillon R; Mathieu C
    Clin Exp Immunol; 2002 May; 128(2):213-20. PubMed ID: 11985511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
    Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
    Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
    Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
    Baumann EE; Buckingham F; Herold KC
    Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.
    van Etten E; Gysemans C; Verstuyf A; Bouillon R; Mathieu C
    Transplant Proc; 2001 May; 33(3):2319. PubMed ID: 11377545
    [No Abstract]   [Full Text] [Related]  

  • 9. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
    Van Etten E; Decallonne B; Verlinden L; Verstuyf A; Bouillon R; Mathieu C
    J Cell Biochem; 2003 Feb; 88(2):223-6. PubMed ID: 12520518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. InsB9-23 Gene Transfer to Hepatocyte-Based Combined Therapy Abrogates Recurrence of Type 1 Diabetes After Islet Transplantation.
    Russo F; Citro A; Squeri G; Sanvito F; Monti P; Gregori S; Roncarolo MG; Annoni A
    Diabetes; 2021 Jan; 70(1):171-181. PubMed ID: 33122392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.
    Kuhn C; Rezende RM; da Cunha AP; Valette F; Quintana FJ; Chatenoud L; Weiner HL
    J Autoimmun; 2017 Jan; 76():115-122. PubMed ID: 27745778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
    Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
    Chatenoud L; Thervet E; Primo J; Bach JF
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive cell therapy using antigen-specific CD4⁻CD8⁻T regulatory cells to prevent autoimmune diabetes and promote islet allograft survival in NOD mice.
    Zhang D; Zhang W; Ng TW; Wang Y; Liu Q; Gorantla V; Lakkis F; Zheng XX
    Diabetologia; 2011 Aug; 54(8):2082-92. PubMed ID: 21594554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.